MSC-mediated mitochondrial transfer holds therapeutic promise for Leber's hereditary optic neuropathy patients

byScience China PressPatch-clamp recordings demonstrated that LHON neurons, which typically exhibit impaired sodium and potassium currents, showed restored electrophysiological function after co

Ophthalmology September 10,2024 0

MSC-mediated mitochondrial transfer holds therapeutic promise for Leber's hereditary optic neuropathy patients

byScience China PressPatch-clamp recordings demonstrated that LHON neurons, which typically exhibit impaired sodium and potassium currents, showed restored electrophysiological function after co

Ophthalmology September 10,2024 0

Old chemo drug, new pancreatic cancer therapy?

Oncology September 10,2024 0

Old chemo drug, new pancreatic cancer therapy?

Oncology September 10,2024 0

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Oncology September 10,2024 0

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Oncology September 10,2024 0

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Oncology September 10,2024 0

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Oncology September 10,2024 0

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

Oncology September 10,2024 0

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

Oncology September 10,2024 0

Potential new drug could target rare childhood brain tumor

Potential new drug could target rare childhood brain tumorA type of glioma. Credit: David Ellison, St. Jude Children’s Research HospitalRibociclib—a drug already used to treat breast cancer—may help s

Oncology September 10,2024 0

Potential new drug could target rare childhood brain tumor

Potential new drug could target rare childhood brain tumorA type of glioma. Credit: David Ellison, St. Jude Children’s Research HospitalRibociclib—a drug already used to treat breast cancer—may help s

Oncology September 10,2024 0

AI spots cancer and viral infections with nanoscale precision

byCenter for Genomic RegulationThe image uses two colors to show specific nuclear components which allow researchers to see detailed structures within the cell nucleus at nanoscale resolution. C

AI & medicine September 10,2024 0

AI spots cancer and viral infections with nanoscale precision

byCenter for Genomic RegulationThe image uses two colors to show specific nuclear components which allow researchers to see detailed structures within the cell nucleus at nanoscale resolution. C

AI & medicine September 10,2024 0

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Oncology September 10,2024 0

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m

Oncology September 10,2024 0

Exploring key regulators of programmed cell death in melanoma and the immune system's response

byBrigham and Women’s HospitalExpression of type I interferon receptors by melanoma cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51496-2A new paperpublish

Dermatology September 10,2024 0

Exploring key regulators of programmed cell death in melanoma and the immune system's response

byBrigham and Women’s HospitalExpression of type I interferon receptors by melanoma cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51496-2A new paperpublish

Dermatology September 10,2024 0

New prognostic biomarker identified in small cell lung cancer

byChinese Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.110413Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of

Oncology September 10,2024 0

New prognostic biomarker identified in small cell lung cancer

byChinese Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.110413Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of

Oncology September 10,2024 0